Resource

How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions. Topics discussed include: - The importance of...

Resource

Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU Clinical Trial Regulation became compulsory for all new interventional clinical trials of investigational medicinal products. All ongoing trials approved under the previous regulatory framework (EU...

Resource

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: - The disparity in data capture for pediatric populations. - Considerations...

Marketing & Sales Solutions

Over 30 years supporting marketing and sales teams across the life sciences industry build strategic campaigns to effectively reach consumers globally....

Resource

LifeSci Talks COA Series | Harnessing Implementation Science to Improve Health Outcomes: Methods and Approaches for the Future

Implementation science emerged as a response to the recognition that many effective health interventions and innovations were not being widely adopted or sustained in practice, even when evidence of their efficacy was strong. Join Meredith Smith, Senior Director of Implementation Science of Evidera in conversation with Mark Wade, Global Practice Leader of TransPerfect Life Sciences, as they explore the field of implementation science and its role in improving the translation...

Resource

Intelligent Automation for MDR & IVDR Content: Summary of Safety & Clinical Performance (SSCP), Summary of Performance (SSP), and Selected Labeling

Content requirements under the EU’s MDR and IVDR, including the translation of labeling, marketing, SSCPs, SSPs, and clinical communications, are set to dramatically increase. Currently, most device manufacturers use manual processes and document-based applications like Microsoft Word and InDesign to manage their content. However, manual processes and document-based approaches require additional headcount to handle increased volumes and faster turnarounds. Download our paper...

Medical Affairs

Streamline your medical affairs operations with TransPerfect’s complete suite of content solutions. Achieve omnichannel engagement with your med affairs content. ...

Resource

EU CTR White Paper - Operational Considerations & Challenges

The Clinical Trial Regulation (EU) 536/2014 (CTR) came into effect on January 31, 2022, replacing the previous regulatory framework of the Clinical Trial Directive 2001/20/EC (CTD). This white paper provides an overview of the CTR and its impact on the organizational readiness and operational execution of clinical trials in the European Union (EU) and European Economic Area (EEA) Member States. Discover the main features of the CTR, including the use of the "Regulation...

Resource

Top 10 Prompts to Ask ChatGPT for Optimizing Clinical Trial Recruitment Strategies

Patient recruitment and engagement are critical to the success of clinical trials. Yet despite the tremendous progress made in drug development, recruitment and retention remain major challenges. Over the last 25 years, the industry has attempted to crack the code; however, 86% of trials still don’t meet original enrollment goals. A bit curious yet somewhat cynical, I turned to ChatGPT to see if it could shed some light on this age-old problem. If you’re like me and...

Resource

EU CTR: An Introduction to European Clinical Trial Transparency

Are you looking to stay ahead of the curve in the ever-evolving landscape of European clinical trials? We are thrilled to announce the availability of our newest on-demand webinar, in which we dive deep into the recent changes to the European Clinical Trial Regulation (EU CTR) and how they impact the world of clinical research. Access this webinar and gain invaluable insights on: 1) Overview of the new EU CTR: Understand the latest regulations governing clinical...

Education Hub

TransPerfect Medical Device Solutions is the first supplier to combine ISO 13485, 14971, and 9001 certified, patented language services with validated process automation technologies to meet the content management challenges of evolving regulations....

Resource

Beyond Borders: Navigating the Complexities of Omnichannel Content Strategy for Global and Local Markets

Hosted by Christine Buggle, Senior Director at TransPerfect Life Sciences, in discussion with Ewelina Knigawka, Executive Director of Content and Partnership Excellence at Novartis, and Scott Dille, Digital Content Lead at Novo Nordisk, this session outlined key considerations when implementing a successful global to local omnichannel strategy. Additional topics in the conversation included: - Establishing a global governance structure for omnichannel: Ensuring a...

Resource

Transitioning Clinical Trials Under the EU CTR

The transition from Clinical Trial Directive to Clinical Trial Regulation in Europe adds new requirements and complexities to the clinical development landscape. The required transition of all trials concluding January 1st, 2025 brings about several considerations to ensure compliance. In this webinar featuring TransPerfect Life Sciences Executive Director Pierre-Frederic Omnes, we explore topics surrounding trial transitions, and answer common questions including: • Which...